Trial intelligence / Profile preview

Calcitriol plus calcium carbonate in diabetic osteoporosis

ChiCTR2400079635Phase 4Completed

Sponsor
Chizhou People's Hospital
Start
Jan 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in diabetic bone disease (DBD) comparing Control group: calcium carbonate with Observation group: calcitriol plus calcium carbonate (2 arms). Primary endpoint: Bone mineral density. Started Jan 2024; status: completed.

02

Drugs

calcitriolcalcium carbonate
03

Conditions

diabetic bone disease (DBD)

Beyond the preview

Go deeper on ChiCTR2400079635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400079635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call